0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight juvenile rheumatoid arthritis pipeline insight 2018.Your search for "" gave back 1286283 results.
The global Humira market size was valued at USD 17560 million in 2023 and is forecast to a readjusted size of USD 9840.6 million by 2030 with a CAGR...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. The “Tumor Necrosis Factor Inhibitor Drug Industry...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Celecoxib, sold under the brand name Celebrex among others, is a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It is used to treat the...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Granulocyte Macrophage Colony Stimulating Factor (GMCSF or Colony Stimulating Factor or CSF or Molgramostin or Sargramostim or CSF2) - Pipeline...
Catalog:
Global Markets Direct
April 2018
Price: USD 3,500.00
Melanocyte Stimulating Hormone Receptor - Pipeline Review, H1 2020 Summary According to the recently published report 'Melanocyte Stimulating...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Macrophage Migration Inhibitory Factor (Glycosylation Inhibiting Factor or L Dopachrome Isomerase or L Dopachrome Tautomerase or Phenylpyruvate...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021 Summary Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR...
Catalog:
Global Markets Direct
July 2021
Price: USD 3,500.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Adenosine Receptor A3 - Pipeline Review, H1 2020 Summary According to the recently published report 'Adenosine Receptor A3 - Pipeline Review, H1...
Catalog:
Global Markets Direct
April 2020
Price: USD 3,500.00
Etanercept are biopharmaceutical anti-Tumor Necrosis Factor (TNF) that treats autoimmune diseases such as arthritis and spondylitis. The “Etanercept...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Tumor necrosis factor inhibitor drug helps to stop physiologic response to tumor necrosis factor. According to our Publisher latest study, the global...
Catalog:
GIR
February 2023
Price: USD 3,480.00
Tyrosine Protein Kinase JAK2 (Janus Kinase 2 or JAK2 or EC 2.7.10.2) - Pipeline Review, H1 2018 Summary Tyrosine Protein Kinase JAK2 (Janus Kinase 2...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Pipeline Review, H2 2018 Summary According to the recently...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline...
Catalog:
Global Markets Direct
July 2018
Price: USD 3,500.00
